It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Details
Title
Author Correction: Antibodies targeting the glycan cap of Ebola virus glycoprotein are potent inducers of the complement system
Author
Ilinykh, Philipp A. 1 ; Huang, Kai 1
; Gunn, Bronwyn M. 2
; Kuzmina, Natalia A. 1
; Kedarinath, Kritika 1 ; Jurado-Cobena, Eduardo 1
; Zhou, Fuchun 1 ; Subramani, Chandru 1 ; Hyde, Matthew A. 3 ; Velazquez, Jalene V. 4 ; Williamson, Lauren E. 5
; Gilchuk, Pavlo 5 ; Carnahan, Robert H. 6
; Alter, Galit 2 ; Crowe, James E. 7
; Bukreyev, Alexander 8
1 University of Texas Medical Branch, Department of Pathology, Galveston, USA (GRID:grid.176731.5) (ISNI:0000 0001 1547 9964); Galveston National Laboratory, Galveston, USA (GRID:grid.176731.5) (ISNI:0000 0001 1547 9964)
2 Ragon Institute of MGH, MIT and Harvard, Cambridge, USA (GRID:grid.461656.6) (ISNI:0000 0004 0489 3491)
3 Galveston National Laboratory, Galveston, USA (GRID:grid.176731.5) (ISNI:0000 0001 1547 9964)
4 Washington State University, Paul G. Allen School of Global Health, Pullman, USA (GRID:grid.30064.31) (ISNI:0000 0001 2157 6568)
5 Vanderbilt University Medical Center, Vanderbilt Vaccine Center, Nashville, USA (GRID:grid.412807.8) (ISNI:0000 0004 1936 9916)
6 Vanderbilt University Medical Center, Vanderbilt Vaccine Center, Nashville, USA (GRID:grid.412807.8) (ISNI:0000 0004 1936 9916); Vanderbilt University Medical Center, Department of Pediatrics, Nashville, USA (GRID:grid.412807.8) (ISNI:0000 0004 1936 9916)
7 Vanderbilt University Medical Center, Vanderbilt Vaccine Center, Nashville, USA (GRID:grid.412807.8) (ISNI:0000 0004 1936 9916); Vanderbilt University Medical Center, Department of Pediatrics, Nashville, USA (GRID:grid.412807.8) (ISNI:0000 0004 1936 9916); Vanderbilt University Medical Center, Department of Pathology, Microbiology, and Immunology, Nashville, USA (GRID:grid.412807.8) (ISNI:0000 0004 1936 9916)
8 University of Texas Medical Branch, Department of Pathology, Galveston, USA (GRID:grid.176731.5) (ISNI:0000 0001 1547 9964); Galveston National Laboratory, Galveston, USA (GRID:grid.176731.5) (ISNI:0000 0001 1547 9964); University of Texas Medical Branch, Department of Microbiology and Immunology, Galveston, USA (GRID:grid.176731.5) (ISNI:0000 0001 1547 9964)








1 University of Texas Medical Branch, Department of Pathology, Galveston, USA (GRID:grid.176731.5) (ISNI:0000 0001 1547 9964); Galveston National Laboratory, Galveston, USA (GRID:grid.176731.5) (ISNI:0000 0001 1547 9964)
2 Ragon Institute of MGH, MIT and Harvard, Cambridge, USA (GRID:grid.461656.6) (ISNI:0000 0004 0489 3491)
3 Galveston National Laboratory, Galveston, USA (GRID:grid.176731.5) (ISNI:0000 0001 1547 9964)
4 Washington State University, Paul G. Allen School of Global Health, Pullman, USA (GRID:grid.30064.31) (ISNI:0000 0001 2157 6568)
5 Vanderbilt University Medical Center, Vanderbilt Vaccine Center, Nashville, USA (GRID:grid.412807.8) (ISNI:0000 0004 1936 9916)
6 Vanderbilt University Medical Center, Vanderbilt Vaccine Center, Nashville, USA (GRID:grid.412807.8) (ISNI:0000 0004 1936 9916); Vanderbilt University Medical Center, Department of Pediatrics, Nashville, USA (GRID:grid.412807.8) (ISNI:0000 0004 1936 9916)
7 Vanderbilt University Medical Center, Vanderbilt Vaccine Center, Nashville, USA (GRID:grid.412807.8) (ISNI:0000 0004 1936 9916); Vanderbilt University Medical Center, Department of Pediatrics, Nashville, USA (GRID:grid.412807.8) (ISNI:0000 0004 1936 9916); Vanderbilt University Medical Center, Department of Pathology, Microbiology, and Immunology, Nashville, USA (GRID:grid.412807.8) (ISNI:0000 0004 1936 9916)
8 University of Texas Medical Branch, Department of Pathology, Galveston, USA (GRID:grid.176731.5) (ISNI:0000 0001 1547 9964); Galveston National Laboratory, Galveston, USA (GRID:grid.176731.5) (ISNI:0000 0001 1547 9964); University of Texas Medical Branch, Department of Microbiology and Immunology, Galveston, USA (GRID:grid.176731.5) (ISNI:0000 0001 1547 9964)
Pages
921
Publication year
2024
Publication date
2024
e-ISSN
23993642
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3086478478
Copyright
© The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.